Emerging recognition of the complement system in hepatic ischemia/reperfusion injury, liver regeneration and recovery (Review)
- Authors:
- Zhi-Gao Hu
- Yi Zhou
- Cheng-Jie Lin
- Guan-Dou Yuan
- Song-Qing He
-
Affiliations: Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China - Published online on: January 18, 2021 https://doi.org/10.3892/etm.2021.9654
- Article Number: 223
-
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
Gracia-Sancho J, Casillas-Ramirez A and Peralta C: Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update. Clin Sci (Lond). 129:345–362. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Saidi RF and Kenari SK: Liver ischemia/reperfusion injury: an overview. J Invest Surg. 27:366–379. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Jaeschke H: Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 290:G1083–G1088. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Nastos C, Kalimeris K, Papoutsidakis N, Tasoulis MK, Lykoudis PM, Theodoraki K, Nastou D, Smyrniotis V and Arkadopoulos N: Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev. 2014(906965)2014.PubMed/NCBI View Article : Google Scholar | |
|
Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH and Mollnes TE: The role of complement in liver injury, regeneration, and transplantation. Hepatology. 70:725–736. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhou Y, Zhang J, Lei B, Liang W, Gong J, Zhao C, Yu J, Li X, Tang B and Yuan S: DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO-1 pathway. Mol Med Rep. 16:6214–6221. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Lu L, Zhou H, Ni M, Wang X, Busuttil R, Kupiec-Weglinski J and Zhai Y: Innate immune regulations and liver ischemia-reperfusion injury. Transplantation. 100:2601–2610. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Jaeschke H, Farhood A, Bautista AP, Spolarics Z and Spitzer JJ: Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol. 264:G801–G809. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Arumugam TV, Woodruff TM, Stocks SZ, Proctor LM, Pollitt S, Shiels IA, Reid RC, Fairlie DP and Taylor SM: Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. J Hepatol. 40:934–941. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Atkinson C, He S, Morris K, Qiao F, Casey S, Goddard M and Tomlinson S: Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol. 185:7007–7013. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Marshall KM, He S, Zhong Z, Atkinson C and Tomlinson S: Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. J Exp Med. 211:1793–1805. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E and Geller DA: Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 147:153–159. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Quesnelle KM, Bystrom PV and Toledo-Pereyra LH: Molecular responses to ischemia and reperfusion in the liver. Arch Toxicol. 89:651–657. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Klune JR and Tsung A: Molecular biology of liver ischemia-reperfusion injury: Established mechanisms and recent advancements. Surg Clin North Am. 90:665–677. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Ye J, Xue M, Liu Y, Zhu S, Li Y, Liu X, Cai D, Rui J and Zhang L: Diosbulbin B-induced mitochondria-dependent apoptosis in L-02 hepatocytes is regulated by reactive oxygen species-mediated autophagy. Front Pharmacol. 10(676)2019.PubMed/NCBI View Article : Google Scholar | |
|
Chavez-Cartaya R, Jamieson NV, Ramirez P, Marin J and Pino-Chavez G: Free radical scavengers to prevent reperfusion injury following warm liver ischemia. Transplant Proc. 31:2439–2440. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Cheng Y and Rong J: Therapeutic potential of heme oxygenase-1-carbon monoxide system against ischemia-reperfusion injury. Curr Pharm Des. 23:3884–3898. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li JY, Gu X, Zhang WH, Jia S and Zhou Y: GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats. Hepatobiliary Pancreat Dis Int. 8:518–523. 2009.PubMed/NCBI | |
|
Oliveira THC, Marques PE, Proost P and Teixeira MMM: Neutrophils: A cornerstone of liver ischemia and reperfusion injury. Lab Invest. 98:51–62. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Sun L, Wu Q, Nie Y, Cheng N, Wang R, Wang G, Zhang D, He H, Ye RD and Qian F: A role for MK2 in enhancing neutrophil-derived ROS production and aggravating liver ischemia-reperfusion injury. Front Immunol. 9(2610)2018.PubMed/NCBI View Article : Google Scholar | |
|
Jaeschke H, Farhood A and Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 4:3355–3359. 1990.PubMed/NCBI | |
|
Jaeschke H, Bautista AP, Spolarics Z and Spitzer JJ: Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun. 15:277–284. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Woodcock SA, Kyriakides C, Wang Y, Austen WG Jr, Moore FD Jr, Valeri R, Hartwell D and Hechtman HB: Soluble P-selectin moderates complement dependent injury. Shock. 14:610–615. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Pemberton M, Anderson G, Vetvicka V, Justus DE and Ross GD: Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol. 150:5104–5113. 1993.PubMed/NCBI | |
|
Panagiotou A, Trendelenburg M and Osthoff M: The lectin pathway of complement in myocardial ischemia/reperfusion injury-review of its significance and the potential impact of therapeutic interference by C1 esterase inhibitor. Front Immunol. 9(1151)2018.PubMed/NCBI View Article : Google Scholar | |
|
Arumugam TV, Magnus T, Woodruff TM, Proctor LM, Shiels IA and Taylor SM: Complement mediators in ischemia-reperfusion injury. Clin Chim Acta. 374:33–45. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Schieferdecker HL, Schlaf G, Jungermann K and Götze O: Functions of anaphylatoxin C5a in rat liver: Direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol. 1:469–481. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Wiese AV, Ender F, Quell KM, Antoniou K, Vollbrandt T, Konig P, Kohl J and Laumonnier Y: The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. PLoS One. 12(e0184956)2017.PubMed/NCBI View Article : Google Scholar | |
|
Guo RF and Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol. 23:821–852. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Winwood PJ and Arthur MJ: Kupffer cells: Their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis. 13:50–59. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Zhang LY, Zhan DL, Chen YY, Wang WH, He CY, Lin Y, Lin YC and Lin ZN: Aflatoxin B1 enhances pyroptosis of hepatocytes and activation of Kupffer cells to promote liver inflammatory injury via dephosphorylation of cyclooxygenase-2: An in vitro, ex vivo and in vivo study. Arch Toxicol. 93:3305–3320. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yu Y, Zhong J, Peng L, Wang B, Li S, Huang H, Deng Y, Zhang H, Yang R, Wang C, et al: Tacrolimus downregulates inflammation by regulating pro-/anti-inflammatory responses in LPS-induced keratitis. Mol Med Rep. 16:5855–5862. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL and Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest. 105:1363–1371. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Vollmar B, Menger MD, Glasz J, Leiderer R and Messmer K: Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol. 267:G786–G793. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Wang L, Vijayan V, Jang MS, Thorenz A, Greite R, Rong S, Chen R, Shushakova N, Tudorache I, Derlin K, et al: Labile heme aggravates renal inflammation and complement activation after ischemia reperfusion injury. Front Immunol. 10(2975)2019.PubMed/NCBI View Article : Google Scholar | |
|
Lai W, Xie X, Zhang X, Wang Y, Chu K, Brown J, Chen L and Hong G: Inhibition of complement drives increase in early growth response proteins and neuroprotection mediated by Salidroside after cerebral ischemia. Inflammation. 41:449–463. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Schönermark M, Deppisch R, Riedasch G, Rother K and Hänsch GM: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol. 96:331–337. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Hattori R, Hamilton KK, McEver RP and Sims PJ: Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 264:9053–9060. 1989.PubMed/NCBI | |
|
Fondevila C, Shen XD, Tsuchihashi S, Uchida Y, Freitas MC, Ke B, Busuttil RW and Kupiec-Weglinski JW: The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury. Liver Transpl. 14:1133–1141. 2008.PubMed/NCBI View Article : Google Scholar | |
|
He S, Atkinson C, Evans Z, Ellett JD, Southwood M, Elvington A, Chavin KD and Tomlinson S: A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury. J Immuno. l183:4764–4772. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Mao SA, Glorioso JM and Nyberg SL: Liver regeneration. Transl Res. 163:352–362. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ibrahim S and Weiss TS: Augmenter of liver regeneration: Essential for growth and beyond. Cytokine Growth Factor Rev. 45:65–80. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Tao Y, Wang M, Chen E and Tang H: Liver regeneration. Mediators Inflamm. 2017(4256352)2017.PubMed/NCBI View Article : Google Scholar | |
|
Sergeeva O, Sviridov E and Zatsepin T: Noncoding RNA in liver regeneration-from molecular mechanisms to clinical implications. Semin Liver Dis. 40:70–83. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Szijártó A and Fülöp A: Triggered liver regeneration: From experimental model to clinical implications. European surgical research. Eur Surg Res. 54:148–161. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Mohammed FF and Khokha R: Thinking outside the cell: Proteases regulate hepatocyte division. Trends Cell Biol. 15:555–563. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Jia C: Advances in the regulation of liver regeneration. Expert Rev Gastroenterol Hepatol. 5:105–121. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Michalopoulos GK: Liver regeneration. J Cell Physiol. 213:286–300. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Fausto N and Riehle KJ: Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg. 12:181–189. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE and Lambris JD: The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med. 198:913–923. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A and Lambris JD: C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol. 173:747–754. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA and Lambris JD: A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol. 166:2479–2486. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Clark A, Weymann A, Hartman E, Turmelle Y, Carroll M, Thurman JM, Holers VM, Hourcade DE and Rudnick DA: Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol. 45:3125–3132. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Daveau M, Benard M, Scotte M, Schouft MT, Hiron M, Francois A, Salier JP and Fontaine M: Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. J Immunol. 173:3418–3424. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Castellano G, Franzin R, Sallustio F, Stasi A, Banelli B, Romani M, De Palma G, Lucarelli G, Divella C, Battaglia M, et al: Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury. Aging (Albany NY). 11:4382–4406. 2019.PubMed/NCBI View Article : Google Scholar | |
|
He S, Atkinson C, Qiao F, Cianflone K, Chen X and Tomlinson S: A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest. 119:2304–2316. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Song H, He C, Knaak C, Guthridge JM, Holers VM and Tomlinson S: Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest. 111:1875–1885. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Alawieh A, Langley EF, Weber S, Adkins D and Tomlinson S: Identifying the role of complement in triggering neuroinflammation after traumatic brain injury. J Neurosci. 38:2519–2532. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Schnabolk G, Parsons N, Obert E, Annamalai B, Nasarre C, Tomlinson S, Lewin AS and Rohrer B: Delivery of CR2-fH using AAV vector therapy as treatment strategy in the mouse model of choroidal neovascularization. Mol Ther Methods Clin Dev. 9:1–11. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Parsons N, Annamalai B, Obert E, Schnabolk G, Tomlinson S and Rohrer B: Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization. Mol Immunol. 108:8–12. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Banda N, Levitt B, Glogowska M, Thurman J, Takahashi K, Stahl G, Tomlinson S, Arend W and Holers V: Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. J Immunol. 183:5928–5937. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wang B, Xu H, Li J, Gao HM, Xing YH, Lin Z, Li HJ, Wang YQ and Cao SH: Complement depletion with cobra venom factor alleviates acute hepatic injury induced by ischemia-reperfusion. Mol Med Rep. 18:4523–4529. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lehmann TG, Koeppel TA, Münch S, Heger M, Kirschfink M, Klar E and Post S: Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc Res. 62:284–292. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Heijnen BH, Straatsburg IH, Padilla ND, Van Mierlo GJ, Hack CE and Van Gulik TM: Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model. Clin Exp Immunol. 143:15–23. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Bongoni A, Lu B, Salvaris E, Roberts V, Fang D, McRae J, Fisicaro N, Dwyer K and Cowan P: Overexpression of human CD55 and CD59 or treatment with human CD55 protects against renal ischemia-reperfusion injury in mice. J Immunol. 198:4837–4845. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Hu W, Xing W, You T, Xu J, Qin X and Peng Z: The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol. 179:2876–2884. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, Huber-Lang M, Piemontese S, Assanelli A, Garlanda C, et al: The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 215(108450)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Johnston K, Popoff E, Myren KJ, Cheung A, Faria C and Tomazos I: A US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome. J Med Econ. 10:1–13. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Peipert JD, Kulasekararaj AG, Gaya A, Langemeijer SMC, Yount S, Gonzalez-Fernandez FA, Ojeda Gutierrez E, Martens C, Sparling A, Webster KA, et al: Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS One. 15(e0237497)2020.PubMed/NCBI View Article : Google Scholar |
